Immunodex

Immudex is a pioneering life science company specializing in the development and commercialization of MHC Dextramer technology for the precise monitoring of antigen-specific T-cell responses. The company's proprietary Dextramer platform offers superior sensitivity and stability compared to traditional multimers, enabling researchers to detect and characterize rare T-cell populations across oncology, infectious diseases, and autoimmunity. Immudex provides a comprehensive suite of products, including dCODE Dextramer for single-cell multi-omics and clinical-grade reagents for immune monitoring in clinical trials. Headquartered in Copenhagen, Denmark, the company serves as a critical partner for global pharmaceutical companies and academic institutions in the discovery and validation of next-generation immunotherapies and vaccines.